Results

Total Results: 852 records

Showing results for "colorectal cancer screening".
Users also searched for: colonoscopy

  1. www.ahrq.gov/sites/default/files/2024-12/nishimi-report.pdf
    January 01, 2024 - • Unusable guidelines (e.g., screening for depression or cholesterol levels in the general population
  2. www.ahrq.gov/research/findings/final-reports/stpra/stpraapa.html
    April 01, 2018 - Methods Data collected in three phases: Phase I, Preliminary Screening Questionnaire Survey; Phase … In general, surveillance or screening have been shown to be effective preventative measures for reducing
  3. www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZYao53-sqRb6oZzKzDmjjt
    December 01, 2003 - The Screening and Interventions for Obesity in Adults: Summary of the Evidence for the U.S. … Methods We developed an analytic framework of obesity screening components, with key questions, and … Results Although no RCTs evaluated obesity screening efficacy, we found studies that address obesity … Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring … RCT 0 Mass screening Epidemiology of obesity a.
  4. www.ahrq.gov/es/patient-safety/settings/hospital/vtguide/guide4.html
    October 01, 2022 - This model was not designed as a screening tool to be embedded in admission order sets.
  5. www.ahrq.gov/patient-safety/settings/hospital/vtguide/guide4.html
    October 01, 2022 - This model was not designed as a screening tool to be embedded in admission order sets.
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-draft-appendix-d1.xlsx
    January 01, 2024 - Draft - Primary Hypofractionated Radiation Therapy for Localized Prostate Cancer: Appendix D1 Tables Table D-1. Study Characteristic Author, year Trial name NCT # Key Questions Study design Funding source Follow-up Assessment Timepoints Indicate all timepoints at which follow-up assessments were completed in months.…
  7. psnet.ahrq.gov/web-mm/what-happened-telemetry
    January 18, 2012 - September 24, 2016 Reducing the risk of delayed colorectal cancer diagnoses through an
  8. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/research-gap-primary-care-summary-table.pdf
    March 01, 2022 - Design • Studies among older adults to confirm the reliability, validity, and factor structure of screening … had complicated diverticulitis (with abscess, peritonitis, etc.) are at increased risk of having colorectalcancer, advanced colonic neoplasia, or advanced adenoma … • Screening rates are higher with patient navigation for colorectal, breast, and cervical cancer; … telephone calls and prompts for colorectal cancer; and reminders with lay health workers for breast
  9. www.ahrq.gov/diagnostic-safety/resources/issue-briefs/state-of-science-5.html
    June 01, 2020 - Missed opportunities to initiate endoscopic evaluation for colorectal cancer diagnosis. … Identifying diagnostic errors in primary care using an electronic screening algorithm.
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-prepub-final-research-appendix-c.xlsx
    January 01, 2024 - Australia RCT cross-over < 2004 No industry funding Reported (Yes COI) Community Family history of colorectalcancer Use of laxatives or medications that affect bowel 4wk before study 3 wk 1 wk 5/21 d Days 15-21 … and consumption of pre- or probiotics or any fibre supplement during the last month prior to screening … , any unexplained weight loss or weight gain of >5 kg in the 1 month prior to the screening, or if they … ; having changed their usual dietary intake/pattern within the 28 days preceding screening; being on
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-final-appendix-c.xlsx
    January 01, 2024 - Australia RCT cross-over < 2004 No industry funding Reported (Yes COI) Community Family history of colorectalcancer Use of laxatives or medications that affect bowel 4wk before study 3 wk 1 wk 5/21 d Days 15-21 … and consumption of pre- or probiotics or any fibre supplement during the last month prior to screening … , any unexplained weight loss or weight gain of >5 kg in the 1 month prior to the screening, or if they … ; having changed their usual dietary intake/pattern within the 28 days preceding screening; being on
  12. hcup-us.ahrq.gov/reports/natstats/his95/table1.pdf
    February 11, 2011 - including parasitic [8.] 17,551 0.05 $11,424 $3,853 $6,748 $12,199 6.2 2.4 48.3 45 1.5 Immunizations and screening … $7,017 5.3 0.4 62.1 47 2 Neoplasms 2,048,837 5.89 $15,623 $5,524 $9,263 $16,829 6.6 6.1 40.2 60 2.1 Colorectalcancer 160,003 0.46 $22,046 $10,910 $16,926 $26,059 10.2 5.1 48.8 70 7 Table 1 Statistics for 1995 … 17.2.4 Other aftercare [257.] 71,163 0.20 $10,372 $3,086 $5,975 $12,392 12.8 4.7 38.4 64 17.2.5 Other screening
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-health-systems-guidelines-development.pdf
    February 01, 2019 - previously participated on panels responsible for developing guidelines for our health system regarding colorectalcancer screening, cystic fibrosis, and supplemental feeding in neonates. … A content expert involved in developing colorectal cancer guidelines echoed the benefit of using the … s guideline development teams for Cystic Fibrosis, Supplemental Feeding in Neonates Guideline, and ColorectalCancer Screening.
  14. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obesity-in-adults-interventions
    September 18, 2018 - Screening for and management of obesity in adults: U.S. … Screening for and Management of Obesity and Overweight in Adults. … The impact of a bodyweight and physical activity intervention (BeWEL) initiated through a national colorectalcancer screening programme: randomised controlled trial. … Risk of colorectal cancer after initiation of orlistat: matched cohort study.
  15. cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2021.pdf
    January 01, 2021 - Logic Updates Metadata Updates Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Part One, ScreeningCancer No N/A No Yes CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for … diabetes-mellitus-part-two-counseling https://cds.ahrq.gov/cdsconnect/artifact/aspirin-therapy-primary-prevention-cvd-and-colorectal-cancer … https://cds.ahrq.gov/cdsconnect/artifact/aspirin-therapy-primary-prevention-cvd-and-colorectal-cancer … https://cds.ahrq.gov/cdsconnect/artifact/aspirin-therapy-primary-prevention-cvd-and-colorectal-cancer
  16. digital.ahrq.gov/sites/default/files/docs/citation/cds-connect-year5-final-report-2021.pdf
    January 01, 2021 - Logic Updates Metadata Updates Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Part One, ScreeningCancer No N/A No Yes CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for … diabetes-mellitus-part-two-counseling https://cds.ahrq.gov/cdsconnect/artifact/aspirin-therapy-primary-prevention-cvd-and-colorectal-cancer … https://cds.ahrq.gov/cdsconnect/artifact/aspirin-therapy-primary-prevention-cvd-and-colorectal-cancer … https://cds.ahrq.gov/cdsconnect/artifact/aspirin-therapy-primary-prevention-cvd-and-colorectal-cancer
  17. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/851555/psn-pdf
    July 31, 2023 - infectious, inflammatory, or neoplastic conditions, such as urinary tract infections, diverticulitis, colorectalcancer, intraabdominal abscesses, inflammatory bowel disease, or colitis.
  18. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obesity-in-adults-screening-and-counseling-2003
    December 15, 2003 - We examined evidence for screening and treating obesity in adults. Data Sources. … No trials evaluated obesity mass screening, so we evaluated indirect evidence for efficacy. … Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring … Screening and Interventions for Obesity in Adults . Summary of the Evidence for the U.S. … RCT Mass screening 0 Epidemiology of obesity    a.
  19. hcup-us.ahrq.gov/reports/natstats/his96/table1.pdf
    February 11, 2011 - 16,998 0.05 $11,650 $3,800 $6,591 $12,197 5.8 2.0 47.8 45.1 1.5 Immunizations and screening … Neoplasms 2,027,921 5.82 $16,034 $5,768 $9,691 $17,355 6.3 6.0 40.1 60.0 2.1 Colorectalcancer 165,393 0.47 $22,546 $11,125 $17,159 $26,611 9.7 5.0 48.8 70.8 2.1.1 Cancer … $9,656 $3,077 $5,400 $10,025 9.6 0.1 40.1 30.2 5.10 Personal history of mental disorder, screening … ] 74,484 0.21 $9,650 $3,146 $6,027 $11,197 9.0 4.1 37.8 65.1 17.2.5 Other screening
  20. www.ahrq.gov/sites/default/files/wysiwyg/sdoh/sdoh-environmental-scan.xlsx
    April 29, 2021 - The risk factor categories available are alcohol consumption, asthma, cholesterol awareness, colorectalcancer screening, diabetes, disability, exercise and physical activity, health status, healthcare access

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive